{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:38:07Z","timestamp":1792269487231,"version":"4.4.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,4]]},"DOI":"10.7759\/cureus.113928","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:41:27Z","timestamp":1785836487000},"source":"Crossref","is-referenced-by-count":1,"title":["Atropine-Induced Anticholinergic Syndrome Following Off-Label Sublingual Administration for Refractory Sialorrhea: A Case Report"],"prefix":"10.7759","author":[{"given":"Pedro","family":"Reboredo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita Rosa","family":"Domingos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006981.pub2","article-title":"Treatment for sialorrhea (excessive saliva) in people with motor neuron disease\/amyotrophic lateral sclerosis","volume":"5","author":"Young CA","year":"2011","unstructured":"Young CA, Ellis C, Johnson J, Sathasivam S, Pih N. Treatment for sialorrhea (excessive saliva) in people with motor neuron disease\/amyotrophic lateral sclerosis. Cochrane Database Syst Rev. 2011, 5:CD006981. 10.1002\/14651858.CD006981.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2005.08.018","article-title":"Drooling of saliva: a review of the etiology and management options","volume":"101","author":"Meningaud JP","year":"2006","unstructured":"Meningaud JP, Pitak-Arnnop P, Chikhani L, Bertrand JC. Drooling of saliva: a review of the etiology and management options. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006, 101:48-57. 10.1016\/j.tripleo.2005.08.018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-019-02000-4","article-title":"Hypersalivation: update of the German S2k guideline (AWMF) in short form","volume":"126","author":"Steffen A","year":"2019","unstructured":"Steffen A, Jost W, B\u00e4umer T, et al.. Hypersalivation: update of the German S2k guideline (AWMF) in short form. J Neural Transm (Vienna). 2019, 126:853-62. 10.1007\/s00702-019-02000-4","journal-title":"J Neural Transm (Vienna)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/ipd.12219","article-title":"Sublingual administration of atropine eyedrops in children with excessive drooling - a pilot study","volume":"27","author":"Norderyd J","year":"2017","unstructured":"Norderyd J, Graf J, Marcusson A, et al.. Sublingual administration of atropine eyedrops in children with excessive drooling - a pilot study. Int J Paediatr Dent. 2017, 27:22-9. 10.1111\/ipd.12219","journal-title":"Int J Paediatr Dent"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2010.02.007","article-title":"Sublingual atropine drops for the treatment of pediatric sialorrhea","volume":"40","author":"Rapoport A","year":"2010","unstructured":"Rapoport A. Sublingual atropine drops for the treatment of pediatric sialorrhea. J Pain Symptom Manage. 2010, 40:783-8. 10.1016\/j.jpainsymman.2010.02.007","journal-title":"J Pain Symptom Manage"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282X20170033","article-title":"Treatment of drooling with sublingual atropine sulfate in children and adolescents with cerebral palsy","volume":"75","author":"Dias BL","year":"2017","unstructured":"Dias BL, Fernandes AR, Maia HS Filho. Treatment of drooling with sublingual atropine sulfate in children and adolescents with cerebral palsy. Arq Neuropsiquiatr. 2017, 75:282-7. 10.1590\/0004-282X20170033","journal-title":"Arq Neuropsiquiatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1708552","article-title":"Sublingual atropine sulfate use for sialorrhea in pediatric patients","volume":"9","author":"Azapa\u011fas\u0131 E","year":"2020","unstructured":"Azapa\u011fas\u0131 E, Kendirli T, Perk O, Kutluk G, \u00d6z Tun\u00e7er G, Teber S, \u00c7obano\u011flu N. Sublingual atropine sulfate use for sialorrhea in pediatric patients. J Pediatr Intensive Care. 2020, 9:196-200. 10.1055\/s-0040-1708552","journal-title":"J Pediatr Intensive Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5430\/crim.v3n3p82","article-title":"Ophthalmic atropine for sublingual use: a novel treatment for excessive respiratory secretions","volume":"3","author":"Staffieri P","year":"2016","unstructured":"Staffieri P, Owusu K, Cardinale M, et al.. Ophthalmic atropine for sublingual use: a novel treatment for excessive respiratory secretions. Case Rep Intern Med. 2016, 3:82-6. 10.5430\/crim.v3n3p82","journal-title":"Case Rep Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12165238","article-title":"Examining the role of sublingual atropine for the treatment of sialorrhea in patients with neurodevelopmental disabilities: a retrospective review","volume":"12","author":"Petkus KD","year":"2023","unstructured":"Petkus KD, Noritz G, Glader L. Examining the role of sublingual atropine for the treatment of sialorrhea in patients with neurodevelopmental disabilities: a retrospective review. J Clin Med. 2023, 12:5238. 10.3390\/jcm12165238","journal-title":"J Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14757","article-title":"Atropine-induced toxicity after off-label sublingual administration of eyedrop for sialorrhoea treatment in neurological disabled patients","volume":"87","author":"Michelon H","year":"2021","unstructured":"Michelon H, Larabi IA, Lemoine J, et al.. Atropine-induced toxicity after off-label sublingual administration of eyedrop for sialorrhoea treatment in neurological disabled patients. Br J Clin Pharmacol. 2021, 87:3364-9. 10.1111\/bcp.14757","journal-title":"Br J Clin Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2008.10.025","article-title":"Clinical and bioavailability studies of sublingually administered atropine sulfate","volume":"28","author":"Rajpal S","year":"2010","unstructured":"Rajpal S, Ali R, Bhatnagar A, Bhandari SK, Mittal G. Clinical and bioavailability studies of sublingually administered atropine sulfate. Am J Emerg Med. 2010, 28:143-50. 10.1016\/j.ajem.2008.10.025","journal-title":"Am J Emerg Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/518262-atropine-induced-anticholinergic-syndrome-following-off-label-sublingual-administration-for-refractory-sialorrhea-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:41:27Z","timestamp":1785836487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/518262-atropine-induced-anticholinergic-syndrome-following-off-label-sublingual-administration-for-refractory-sialorrhea-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.113928","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}